Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Non-Current Deferred Tax Liability: 2020-2024

Historic Non-Current Deferred Tax Liability for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $32000.0.

  • Oncology Institute's Non-Current Deferred Tax Liability changed 0.0% to $32000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $32000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $32000.0 for FY2024, which is 9968.66% down from last year.
  • Latest data reveals that Oncology Institute reported Non-Current Deferred Tax Liability of $32000.0 as of FY2024, which was down 9968.66% from $10.2 million recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Non-Current Deferred Tax Liability peaked at $10.2 million during FY2023, and registered a low of $32000.0 during FY2024.
  • Over the past 5 years, Oncology Institute's median Non-Current Deferred Tax Liability value was $3.7 million (recorded in 2020), while the average stood at $4.9 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first soared by 32784.06% in 2022, then tumbled by 9968.66% in 2024.
  • Oncology Institute's Non-Current Deferred Tax Liability (Annual) stood at $3.7 million in 2020, then crashed by 45.55% to $2.0 million in 2021, then skyrocketed by 327.84% to $8.7 million in 2022, then increased by 17.38% to $10.2 million in 2023, then crashed by 99.69% to $32000.0 in 2024.
  • Its Non-Current Deferred Tax Liability stands at $32000.0 for FY2024, versus $10.2 million for FY2023 and $8.7 million for FY2022.